Library — CHDR

Search

Filter

Clinical translation of anti-inflammatory effects of in Th1, Th2, and Th17 inflammation.

Itano A, Maslin D, Ramani K, Mehraei G, Carpenter N, Cormack T, Saghari M, Moerland M, Troy E, Caffry W, Wardwell-Scott L, Abel S, McHale D, Bodmer M

Frontiers in medicine, 2023 Nov

View publication
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity.

Zhuparris A, Maleki G, van Londen L, Koopmans I, Aalten V, Yocarini IE, Exadaktylos V, van Hemert A, Cohen A, Gal P, Doll RJ, Groeneveld GJ, Jacobs G, Kraaij W

Scientific reports, 2023 Nov; 13(1):18844

View publication
Sensitivity of cognitive function tests to acute hypoxia in healthy subjects: a systematic literature review.

Post TE, Heijn LG, Jordan J, van Gerven JMA

Frontiers in physiology, 2023 Oct

View publication
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.

Rousel J, Bergmans ME, van der Meulen LWJ, Pagan L, de Bruin DT, de Kam ML, Klarenbeek NB, Bouwstra JA, Seyger MMB, van den Reek JMPA, Niemeyer-van der Kolk T, Rissmann R, van Doorn MBA,

Journal of the American Academy of Dermatology, 2023 Oct

View publication
Smartphone-Based Passive Sensing in Monitoring Patients With Cancer: A Systematic Review.

Stuijt DG, Radanovic I, Kos M, Schoones JW, Stuurman FE, Exadaktylos V, Bins AD, Bosch JJ, van Oijen MGH

JCO clinical cancer informatics, 2023 Sep

View publication
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.

Houvast RD, Badr N, March T, de Muynck LDAN, Sier VQ, Schomann T, Bhairosingh S, Baart VM, Peeters JAHM, van Westen GJP, Plückthun A, Burggraaf J, Kuppen PJK, Vahrmeijer AL, Sier CFM

European journal of nuclear medicine and molecular imaging, 2023 Aug

View publication
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale.

Otto ME, Bergmann KR, de Kam ML, Recourt K, Jacobs GE, van Esdonk MJ

CPT: pharmacometrics & systems pharmacology, 2023 Aug

View publication
Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study.

In 't Veld AE, Grievink HW, van der Plas JL, Eveleens Maarse BC, van Kraaij SJW, Woutman TD, Schoonakker M, Klarenbeek NB, de Kam ML, Kamerling IMC, Jansen MAA, Moerland M

Immunologic research, 2023 Aug; 71(4):617-627

View publication
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls.

Vissers MFJM, Troyer MD, Thijssen E, Pereira DR, Heuberger JAAC, Groeneveld GJ, Huntwork-Rodriguez S

Clinical and translational science, 2023 Aug; 16(8):1408-1420

View publication

«
1
2
3
4
5
6
7
8
...
98
99
»